相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
Ali Manouchehrinia et al.
NEUROLOGY (2020)
A multi-center study of neurofilament assay reliability and inter-laboratory variability
Elizabeth Gray et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS
L. Novakova et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke
Fani Pujol-Calderon et al.
NEUROSCIENCE LETTERS (2019)
Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
Maria Pia Sormani et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Irene Hakansson et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Neurofilaments and 10-year follow-up in multiple sclerosis
Alok Bhan et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
M. Vagberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
Lenka Novakova et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
I. Hakansson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis
Jan Lycke et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova et al.
NEUROLOGY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
The Swedish MS registry - clinical support tool and scientific resource
J. Hillert et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
Markus Axelsson et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Tobias Skillback et al.
NEUROLOGY (2014)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Editors' welcome and a working definition for a multiple sclerosis cure
Brenda Banwell et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2013)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Neurochemical aftermath of amateur boxing
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2006)
Spinal cord abnormalities in recently diagnosed MS patients
JCJ Bot et al.
NEUROLOGY (2004)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
F Cotton et al.
NEUROLOGY (2003)